Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pre-spinal fluid therapy comparison before elective cesarean section
IRCT2016110730770N1Phase 3Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ringer's solution, dextrose + sodium chloride and hetastarch in Cardiovascular collapse, sponsored by Zahedan University of Medical Sciences. Primary endpoint: Maternal hemodynamic effects. Started Jan 2017; status: completed.
02
Drugs
ringer's solutiondextrose + sodium chloridehetastarch
03
Conditions
Cardiovascular collapse
Beyond the preview
Go deeper on IRCT2016110730770N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2016110730770N1.